CN1820017A - 4＂位取代的大环内酯类 - Google Patents

4＂位取代的大环内酯类 Download PDF

Info

Publication number
CN1820017A
CN1820017A CNA2004800196558A CN200480019655A CN1820017A CN 1820017 A CN1820017 A CN 1820017A CN A2004800196558 A CNA2004800196558 A CN A2004800196558A CN 200480019655 A CN200480019655 A CN 200480019655A CN 1820017 A CN1820017 A CN 1820017A
Authority
CN
China
Prior art keywords
alkyl
group
hydrogen
compound
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800196558A
Other languages
English (en)
Chinese (zh)
Inventor
S·阿利霍兹克
A·伯迪克
J·M·伯格
R·L·亚维斯特
S·穆塔克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Fidelta doo
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Institut doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Institut doo filed Critical Glaxo Group Ltd
Publication of CN1820017A publication Critical patent/CN1820017A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CNA2004800196558A 2003-05-13 2004-05-11 4＂位取代的大环内酯类 Pending CN1820017A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0310984.0A GB0310984D0 (en) 2003-05-13 2003-05-13 Novel compounds
GB0310984.0 2003-05-13

Publications (1)

Publication Number Publication Date
CN1820017A true CN1820017A (zh) 2006-08-16

Family

ID=9957982

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800196558A Pending CN1820017A (zh) 2003-05-13 2004-05-11 4＂位取代的大环内酯类

Country Status (9)

Country Link
US (1) US20070213283A1 (enExample)
EP (1) EP1625137A1 (enExample)
JP (1) JP2006528947A (enExample)
CN (1) CN1820017A (enExample)
AR (1) AR044308A1 (enExample)
CA (1) CA2525449A1 (enExample)
CL (1) CL2004001007A1 (enExample)
GB (1) GB0310984D0 (enExample)
WO (1) WO2004101585A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108290919A (zh) * 2015-11-19 2018-07-17 艾比恩多制药有限责任公司 具有上皮屏障增强特性的阿奇霉素衍生物
CN114007625A (zh) * 2019-04-18 2022-02-01 阿祖拉眼科有限公司 用于治疗眼病的化合物和方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012923A (es) * 2004-05-06 2007-07-18 Glaxosmithkline Zagreb Macrolidos asociados a ester utiles para el tratamiento de infecciones microbianas.
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
WO2009007988A1 (en) * 2007-07-11 2009-01-15 Alembic Limited Process for the preparation of 6-o-methylerythromycin a 9-oxime

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4686207A (en) * 1985-11-12 1987-08-11 Abbott Laboratories Erythromycin A 11,12-carbonates and method of use
ATE128714T1 (de) * 1989-03-28 1995-10-15 Abbott Lab Erythromycinderivate.
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
CA2253451A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108290919A (zh) * 2015-11-19 2018-07-17 艾比恩多制药有限责任公司 具有上皮屏障增强特性的阿奇霉素衍生物
CN108290919B (zh) * 2015-11-19 2022-06-17 艾比恩多制药有限责任公司 具有上皮屏障增强特性的阿奇霉素衍生物
CN114007625A (zh) * 2019-04-18 2022-02-01 阿祖拉眼科有限公司 用于治疗眼病的化合物和方法

Also Published As

Publication number Publication date
CL2004001007A1 (es) 2005-03-18
AR044308A1 (es) 2005-09-07
EP1625137A1 (en) 2006-02-15
JP2006528947A (ja) 2006-12-28
WO2004101585A1 (en) 2004-11-25
CA2525449A1 (en) 2004-11-25
GB0310984D0 (en) 2003-06-18
US20070213283A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
CN1273475C (zh) 具有抗细菌活性的6－0－取代的酮基内酯类化合物
CN1244202A (zh) 三环红霉素衍生物
CN1241931C (zh) 大环内酯抗感染药物
CN1052984C (zh) 新的红霉素衍生物、其制备方法及其作为药物的应用
CN100338061C (zh) 炔－芳基磷酸二酯酶－4抑制剂
CN1053668C (zh) 新型化合物及其制法和抗肿瘤剂
CN1612888A (zh) 大环内酯类化合物
CN1240707C (zh) 2－卤代－6－0－取代的酮内酯衍生物
CN1257164C (zh) 芳香酰胺、其制备方法以及作为药物的应用
CN1126997A (zh) 红霉素的新型衍生物，其制备方法及作为药物的应用
CN1088711C (zh) 头孢烯化合物及含该化合物的医药
CN1659178A (zh) 6、11二环红霉素衍生物
CN1343215A (zh) 具有抗菌活性的6－o－取代大环内酯类化合物
CN1278813A (zh) 喹诺酮抗微生物剂、其组合物和应用
CN1009930B (zh) 含喹啉羧酸衍生物的药物组合物的制备方法
CN1157611A (zh) 新的喹诺酮5-(n-杂取代氨基)抗微生物剂
CN1633444A (zh) 6－11双环酮大环内酯衍生物
CN1351608A (zh) 13－甲基红霉素衍生物
CN1238777A (zh) 红霉素a衍生物
CN1271363A (zh) 具有抗菌活性的3’－n－修饰的6－o－取代的红霉素酮基内酯衍生物
CN1543465A (zh) 用作选择性细菌dhfr抑制剂的新的杂环化合物及其应用
CN1630661A (zh) 具有抗菌活性的大环内酯类化合物
CN1820017A (zh) 4＂位取代的大环内酯类
CN1213055C (zh) 核糖取代的新芳族酰胺、其制备方法及其作为药剂的用途
CN1585775A (zh) 可用作抗菌药的红霉素的6－o－酰基酮内酯衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20060816